Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9600 posts found.

Allergan signs $1.5 billion deal with Molecular Partners

August 22, 2012 Research and Development, Sales and Marketing Allergan, Molecular Partners, eye diseases

Allergan has signed a deal potentially worth $1.5 billion with Molecular Partners to develop new drugs for certain eye diseases. …
News
screen_shot_2012-08-22_at_09

Lundbeck makes two senior appointments

August 22, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andreas Eggert, Klaus Abel, Lundbeck

Lundbeck has appointed Andreas Eggert (pictured) as senior vice president for global product strategy, and Klaus Abel as vice president …
Appointment

Pfizer’s arthritis drug delayed by FDA

August 21, 2012 Research and Development, Sales and Marketing FDA, Pfizer, tofacitinib

Pfizer says its new rheumatoid arthritis drug tofacitinib has been delayed by the FDA. Tofacitinib, an oral Janus kinase (JAK) …
News
screen_shot_2012-08-21_at_09

INC Research promotes Jamie Macdonald to chief executive

August 21, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing INC Research, Jamie Macdonald

Clinical research organisation INC Research has announced chief operating officer Jamie Macdonald will become the firm’s next president and chief …
Appointment

GSK severe asthma drug progresses to Phase III

August 20, 2012 Research and Development, Sales and Marketing Advair, GSK, Phase II, asthma, phase III

GlaxoSmithKline’s severe asthma drug mepolizumab has impressed in a mid-stage study, meaning it can now progress into Phase III testing. …
News

Zaicom MMC appoints new medical writer

August 17, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Katharine Peregrín, Zaicom MMC

Comms agency Zaicom MMC, part of the Zaicom International group of companies, has appointed Katharine Peregrín as a medical writer.  …
Appointment

The number one reason for a failed project

August 16, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Communication, Failed project, Les Rose, clinical trials

There was once a company that had an amusing form of words for admonishing people. It went something like this: …
Feature
Tsyabri image

Elan to spin off drug discovery arm

August 14, 2012 Research and Development, Sales and Marketing Elan, Neotype Biosciences, Tysabri, multiple sclerosis

Elan Corporation is to spin off its drug discovery arm Neotype Biosciences to create a separate, quoted company by the …
News
novartis_window

New Avastin data could be bad news for Lucentis

August 14, 2012 Research and Development, Sales and Marketing DMO, Lucentis, Novartis, Roche, avastin, off label, off-label, wet AMD

The day after Novartis gained a new US licence for Lucentis to treat diabetic macular oedema, new data was published …
News
dr_susan_wood

Astellas Pharma Europe appoints new senior director

August 14, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Susan Wood

Astellas Pharma Europe has appointed Dr Susan Wood as senior director, Market Access. Formerly senior brand director of APEL’s Pain Management …
Appointment

Novartis pledges to maintain R&D presence in Horsham

August 14, 2012 Manufacturing and Production, Research and Development Horsham, NIBR, Novartis, R&D, cuts

Novartis has confirmed that it intends to maintain a presence at its site in Horsham, UK, which has already seen …
News
Avastin image

Avastin sees success in brain cancer trial

August 13, 2012 Research and Development, Sales and Marketing R&D, avastin, brain cancer

A late-stage study has shown that Roche’s oncology drug Avastin, when added to standard therapy, can help people with brain …
News
Pfizer image

Torisel-Avastin combo fails in kidney cancer

August 13, 2012 Research and Development, Sales and Marketing R&D, Sutent, Torisel, avastin, failure, rcc

Combining Pfizer’s Torisel and Roche’s Avastin does not increase survival rates for advanced kidney cancer patients. This is according to …
News

Contract research news in brief

August 10, 2012 Research and Development Accenture, Charles River Labs, ICON, Octagon Research Solutions, Phlexglobal, Quanticate, Verum

ICON plans UK investment, Verum expands in the US, plus updates from Charles River, Phlexglobal, Accenture/Octagon and Quanticate.
News

Pfizer signs drug profiling deal with Nodality

August 10, 2012 Research and Development, Sales and Marketing Lupus, Nodality, Pfizer, SCNP

Pfizer has signed a multi-year drug profiling deal with Nodality to help get the best from its autoimmune disease compounds. …
News
The Gateway to Local Adoption Series

Latest content

Five Facts about the menopause

March 6, 2026

Zello Appoints Kevin Bailey as Group Chief Medical Officer

March 6, 2026

BioDuro establishes joint manufacturing venture with Cenra

March 6, 2026

Symbiosis appoints Joanne Anderson as Chief Commercial Officer

March 6, 2026

Secarna Pharmaceuticals and Curie.Bio expand existing partnership

March 6, 2026